Clinical Trials on Type 2 Diabetes Mellitus ;Obesity,High Triglycerides；TCM in Belgium

Total 160 results

Cliniques universitaires Saint-Luc- Université...

Unknown

Impact of Changes in Muscle Secretome in the Remission of Type 2 Diabetes Mellitus Induced by Bariatric Surgery (MYDIASECRET)

Diabete Type 2

Belgium
University Hospital, Gasthuisberg

Completed

The Effect of a Gastric Bypass on Type 2 Diabetes in the Morbidly Obese Patient

Type 2 Diabetes | Morbid Obesity

Belgium
Hasselt University
Jessa Hospital

Completed

Effect of High-intensity Interval Training on Cardiac Function and Regulation of Glycemic Control in Diabetic Cardiomyopathy

Type2 Diabetes | Diabetic Cardiomyopathies

Belgium
University of Liege
EGID, Lille

Unknown

Research Study for Rare Pathogenic Mutations Causing Type 2 Diabetes and Complications (PreciDiag)

Diabete Type 2

Belgium
Cliniques universitaires Saint-Luc- Université...

Completed

Effect of Exenatide on Glucose Homeostasis Determinants in Type 2 Diabetes

Type 2 Diabetes Mellitus

Belgium
University Ghent
BOF

Completed

Controlled Outcome Evaluations of a Daily Physical Activity Intervention for Individuals With Type 2 Diabetes

Type 2 Diabetes

Belgium
University Ghent

Completed

Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial

Diabetes Mellitus

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Acute Effect of Rebaudioside A on Glucose Excursion During an Oral Glucose Tolerance Test in Type 2 Diabetes Mellitus (AREBAG)

Type 2 Diabetes Mellitus

Belgium
Erasme University Hospital

Terminated

Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.

Type 2 Diabetes | Pancreas | Incretinomimetics

Belgium
India Diabetes Research Foundation & Dr. A. Ramachandran...

Completed

A Study on Comparison of Glargine Plus Glulisine With Premixed Insulin in Type 2 Diabetes Patients

Type2 Diabetes

India
Poitiers University Hospital
Hospices Civils de Lyon; Centre Hospitalier Universitaire Dijon; University Hospital... and other collaborators

Recruiting

Efficacy of a High-intensity Physical Activity Program on Renal Function in High Risk Patients With Type 2 Diabetes (ACTIDIANE)

Diabetic Kidney Disease | Type2 Diabetes

France, Belgium
Sahlgrenska University Hospital, Sweden
Karolinska Institutet; Imperial College London; University Hospital, Ghent; Universitair... and other collaborators

Completed

Early Glycaemic Control in Type 2 Diabetes Patients After Bariatric Surgery; ECODABS

Diabetes Mellitus Type 2 in Obese

Spain, Sweden, Belgium, United Kingdom
Sanofi

Completed

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes (LixiLan-India)

Type 2 Diabetes Mellitus

India
Indigo Diabetes NV

Completed

The SHINE Study: Safety of Implant and Preliminary Performance of the SHINE SYSTEM in Diabetic Subjects

Diabetes Mellitus, Type 2 | Diabetes Mellitus | Hypoglycemia | Diabetes Mellitus, Type 1 | Ketoacidosis, Diabetic | Hyperglycaemia (Diabetic)

Belgium, Slovenia, France
Pfizer

Completed

Single Dose Escalation Study of PF-05190457 in Healthy Volunteers

Diabetes Mellitus, Type II

Belgium
Canterbury Christ Church University
Kinetic Analysis; Medway Community Healthcare; Blackthorn Trust; Arteveldehoges... and other collaborators

Completed

Evaluation of Diabetes and WELLbeing Programme (DWELL)

Type 2 Diabetes | Type 2 Diabetes Treated With Insulin

Belgium, France, Netherlands, United Kingdom
Ziekenhuis Oost-Limburg
Ziekenhuis Oost-Limburg

Recruiting

Characteristics of NAFLD Among Type 2 Diabetes Patients

Type2 Diabetes | Non-Alcoholic Fatty Liver Disease

Belgium
Sanofi

Completed

Dose-Ranging Study Evaluating AVE2268 in Patients With Type 2 Diabetes Not Adequately Controlled by a Metformin Treatment

Type 2 Diabetes Mellitus

France, Poland, Germany, Italy, Netherlands, Belgium, Denmark, Chile, South Africa, Australia, Argentina
Hasselt University
KU Leuven; Jessa Hospital; University Ghent

Recruiting

Prevention of Heart Failure in Type 2 Diabetes by Exercise Intervention (PROTECTION)

Type 2 Diabetes

Belgium
Cliniques universitaires Saint-Luc- Université...

Completed

Effect of GLP-1 Analogs on Psoriasis in Type 2 Diabetic Patients

Psoriasis | Type 2 Diabetes

Belgium
University Ghent

Completed

Identifying the Effect and Working Mechanisms of MyPlan 2.0 in Adults With Type 2 Diabetes

Chronic Disease

Belgium
Novo Nordisk A/S

Completed

Observational Study on Effectiveness and Safety of Liraglutide in Subjects With Type 2 Diabetes (ROOTS)

Diabetes Mellitus, Type 2 | Diabetes

Belgium
Novo Nordisk A/S

Completed

Switch From Metformin Monotherapy to a Bitherapy With Metformin and Repaglinide (REPAMET 2)

Diabetes Mellitus, Type 2 | Diabetes

Belgium
Novo Nordisk A/S

Completed

Observational Study Evaluating the Safety of NovoMix® in Type 2 Diabetes Patients Previously Treated With a Human Premix Insulin (Mix2Mix)

Diabetes Mellitus, Type 2 | Diabetes

Belgium, Luxembourg
Novo Nordisk A/S

Completed

Observational Study of the Switch of Metformin Alone to Metformin Combined With Repaglinide in Type 2 Diabetes (REPAMET)

Diabetes Mellitus, Type 2 | Diabetes

Luxembourg, Belgium
University Hospital, Ghent
University Ghent

Recruiting

24-hour Movement Behaviors Among Type 2 Diabetes Mellitus Patients

Diabetes Mellitus, Type 2

Belgium
Pfizer

Terminated

A Study To Evaluate PF-00915275 In Subjects With Type 2 Diabetes Mellitus For 4-Weeks

Diabetes Mellitus, Type 2

Belgium
KU Leuven

Completed

Impact of an Evidence-based Electronic Decision Support System on Diabetes Care

Diabetes Mellitus, Type 2

Belgium
Hasselt University
Hochschule Geisenheim University

Completed

Orange Juice and Glycaemic Control in Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

Belgium
Pfizer

Completed

A Study Of PF-03882845 Absorption In Healthy Volunteers Given Orally As Tablet Versus Suspension Formulations And Effect Of Food On Its Absorption

Diabetes Mellitus, Type 2

Belgium
Centre d'Etudes et de Recherche pour l'Intensification...

Completed

Validation of a Predictive Risk Equation for Type 2 Diabetes in Families With Risk (DESCENDANCE)

Type 2 Diabetes

France, Belgium
Eli Lilly and Company

Completed

Safety, Tolerability, and Effect of LY2405319 After Multiple Injections in Subjects With Type 2 Diabetes

Type 2 Diabetes

India, Mexico, New Zealand, South Africa
Universitaire Ziekenhuizen KU Leuven
Dutch Health Care Insurance Board

Completed

Effects of Physical Activity Coaching on Health and Behaviour Parameters in Diabetic Persons

Diabetes Mellitus, Type 2

Belgium
AstraZeneca
Eli Lilly and Company

Completed

Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3)

Type 2 Diabetes Mellitus

United States, Czech Republic, France, Korea, Republic of, Russian Federation, Spain, Mexico, Australia, Belgium, Denmark, Germany, Hungary, Netherlands, Puerto Rico, Greece, Taiwan
Sanofi

Completed

Obese Patients With Type 2 Diabetes (RIO-Diabetes)

Obesity | Diabetes Mellitus, Non-Insulin-Dependent | Obesity in Diabetes

United States, France, Canada, Poland, Germany, Netherlands, Belgium, Czech Republic, Argentina, Finland, United Kingdom
AstraZeneca
Eli Lilly and Company

Completed

Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)

Type 2 Diabetes Mellitus

United States, Brazil, Italy, Korea, Republic of, Mexico, Poland, Russian Federation, Spain, Turkey, United Kingdom, South Africa, Argentina, Canada, Germany, Hungary, Israel, Romania, Slovakia, India, Belgium, France, Puerto Rico
AstraZeneca
Eli Lilly and Company

Completed

Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

Australia, France, Italy, Korea, Republic of, Mexico, Spain, Poland, Romania, South Africa, Argentina, Austria, Belgium, Germany, Hungary, Israel, Slovakia, Greece, India, Taiwan, Canada, Czech Republic
AstraZeneca
Eli Lilly and Company

Completed

A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

Sweden, Italy, Korea, Republic of, Mexico, Russian Federation, Spain, Estonia, Romania, Finland, Netherlands, Argentina, Belgium, Germany, Portugal, United Kingdom, Greece, France, Puerto Rico
Sanofi

Completed

24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine (GetGoal-Duo1)

Type 2 Diabetes Mellitus

United States, Argentina, Brazil, Canada, Chile, Colombia, Czech Republic, Denmark, Estonia, France, Germany, Hungary, India, Israel, Italy, Malaysia, Mexico, Netherlands, Poland, Puerto Rico, Romania, Russian Federation, South Africa, Swed... and more
Robert Lodder
University of Kentucky

Completed

A Clinical Study to Evaluate the Effect of Naturlose (Tagatose)

Type 2 Diabetes

United States, India
Universitaire Ziekenhuizen KU Leuven

Completed

Mobile-based Lifestyle Intervention in Women With Glucose Intolerance After Gestational Diabetes (MELINDA)

Type 2 Diabetes Mellitus | Glucose Intolerance | Gestational Diabetes | Healthy Lifestyle

Belgium
Universitaire Ziekenhuizen KU Leuven

Recruiting

Prevalence of Overweight and Obesity in Adult Patients Suffering From Type 1 Diabetes (POOT1)

Obesity | Type 1 Diabetes

Belgium
Becton, Dickinson and Company

Terminated

An Audit of the Impact of Tailored Information Delivered Via a Digital Learning Platform

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

Belgium
Sanofi
Hanmi Pharmaceutical Company Limited

Terminated

Effect of Efpeglenatide on Cardiovascular Outcomes (AMPLITUDE-O)

Type 2 Diabetes Mellitus

Estonia, Spain, Ukraine, Italy, Germany, Canada, Mexico, United States, Argentina, Bulgaria, Chile, Denmark, Finland, Hungary, India, Korea, Republic of, Latvia, Lithuania, Norway, Peru, Poland, Romania, Russian Federation, Serbia, Slov... and more
Novartis

Completed

Efficacy and Safety of Vildagliptin as add-on Therapy to Insulin in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Germany, Romania, Hungary, Belgium, Slovakia, Australia, India, Czech Republic, Guatemala, Hong Kong, United Kingdom
Novartis Pharmaceuticals

Completed

Safety and Efficacy of Galvus in Elderly Type 2 Diabetes Patients

Type 2 Diabetes Mellitus

United Kingdom, Belgium, Bulgaria, Spain, Slovakia, Germany, Finland
Eli Lilly and Company

Active, not recruiting

A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes (SURPASS-CVOT)

Type 2 Diabetes Mellitus

China, United States, Netherlands, Spain, Australia, Austria, India, Canada, Taiwan, Japan, United Kingdom, Belgium, France, Germany, Mexico, Romania, Italy, Argentina, Brazil, Puerto Rico, Ukraine, Hungary, Czechia, Turkey, Korea, Republic... and more
AstraZeneca

Terminated

GALLEX 4 - Long-Term Extension Study to Evaluate Tesaglitazar Therapy in Patients With Type 2 Diabetes

Type 2 Diabetes

Italy, Poland, South Africa, Malaysia, Hungary, Belgium, Slovakia, Philippines, Thailand, Hong Kong
AstraZeneca
Bristol-Myers Squibb

Completed

Efficacy and Tolerability of Saxagliptin add-on Compared to Uptitration of Metformin in Patients With Type 2 Diabetes (PROMPT)

Type 2 Diabetes Mellitus

France, Italy, Turkey, Germany, United Kingdom, Belgium, Spain
Eli Lilly and Company

Active, not recruiting

A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH) (SURPASS-SWITCH)

Type 2 Diabetes

United States, Belgium, Germany, Mexico, Romania

Clinical Trials on Type 2 Diabetes Mellitus ;Obesity,High Triglycerides；TCM in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations